You are here: Home - Investing - Experienced Investor - News -

Stock of the week: Genus

0
Written by: YourMoney.com
29/01/2018
Helal Miah, investment research analyst at The Share Centre, picks world-leading animal genetics company, Genus, as stock of the week.

Global demand for pork, beef and milk is predicted to continue to rise, especially in developing countries, with their rising incomes, population growth and move to urbanisation. Therefore, a company that provides help for farmers to improve efficiency and the quality of its stock looks well positioned for the longer-term. Consumers want affordable, safe to eat and better quality produce and farmers are reacting to that with a growing use of genetics in breeding and improving their stock.

Genus applies science to animal breeding. Its non-genetically modified organism technology is applicable across all livestock species, but is only commercialised by Genus in the cattle and pig farming sectors. It is a provider of genetics and reproduction services, marketing in more than 75 countries. The group believes it has a competitive edge from having ownership and control of its breeding animals, along with the biotechnology used for further improvements, allied to its growing global supply and distribution network and increase spend on research and development.

In recent updates, the company has reassured investors that trading is in line with expectations and that markets remain ‘generally favourable’. Indeed, acquisitions, such as pig genetics specialist Hermitage, should help enhance the group’s global reach and boost royalty growth and the strategic review combined with the increasing focus on researching and sexing technology is expected to increasingly benefit the group.

This is a company that is establishing a niche for itself across the globe. The share price has moved higher since the results hit an all-time high in November, as analysts get excited about its gene editing program. As a result, we would recommend Genus as a medium to higher risk, long-term growth ‘buy’ for investors.

There are 0 Comment(s)

If you wish to comment without signing in, click your cursor in the top box and tick the 'Sign in as a guest' box at the bottom.

Big flu jab price hikes this winter: Where’s cheapest if you can’t get a free vaccine?

Pharmacies, supermarkets and health retailers are starting to offer flu jabs ahead of the winter season, but t...

Is now the time to fix your energy deal?

Fixed energy tariffs all but disappeared during the energy crisis. But now they are back with an increasing nu...

Everything you need to know about the pension triple lock

Retirees are braced to receive another bumper state pension pay rise next year due to the triple lock mechanis...

What will happen if rates change

How your finances will be impacted by a rise in interest rates.

Regular Savings Calculator

Small regular contributions can build up nicely over time.

Online Savings Calculator

Work out how your online savings can build over time.

The best student bank accounts in 2023: Cash offers, tastecards and 0% overdrafts

A number of banks are luring in new student customers with cold hard cash this year – while others are compe...

DIY investors: 10 common mistakes to avoid

For those without the help and experience of an adviser, here are 10 common DIY investor mistakes to avoid.

Mortgage down-valuations: Tips to avoid pulling out of a house sale

Down-valuations are on the rise. So, what does it mean for home buyers, and what can you do?

Money Tips of the Week